Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD
Conclusion: Analysing SGRQ and TDI responders using AUC and mean values allows investigation over a longer period of time and may be a better way to define responders than using only a single timepoint. The results consistently show an improved response of T+O compared to its mono-components.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Derom, E., Watz, H., Grönke, L., Voss, F., Buhl, R. Tags: Clinical Problems COPD Source Type: research
More News: Chronic Obstructive Pulmonary | Clinical Trials | Respiratory Medicine | Spiriva | Study | Tiotropium